By Andrew Jacobs from NYT Health
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
https://ift.tt/3o6rIvB
May 9, 2021 at 06:00AM
0 Comments
Share your opinion